Population Pharmacokinetic Analysis and Pharmacodynamic Evaluation of Sulbactam in Pediatric Patients: Dosing Suggestions for Acinetobacter baumannii Infections
Authors:
Open Access
- 13 May 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 14 (5)
Abstract
Background: This study aims to develop a population pharmacokinetic (PK) model of sulbactam in pediatric patients using pooled data analysis, and to optimize dosing regimens against Acinetobacter baumannii infections. Methods: Publications were systematically identified with MEDLINE for collecting sulbactam PK data in pediatric patients. Sulbactam PK model was developed using plasma concentration–time data gained from identified literature works. Based on the model, we estimated the probability of attaining the pharmacodynamic (PD) target against A. baumannii. Results: The data were adequately described by 2-compartment model. Age was a statistically significant covariate in clearance. Aiming for the PD target of 60% of time above minimum inhibitory concentration in free drug concentrations (fT > MIC), the breakpoint MICs were increased by extending infusion time from 0.5 to 4 hours. The breakpoint MICs for 4-hour infusion regimens of 25 mg/kg 4 times daily (100 mg/kg/day) achieved 4 μg/mL in infants (4 weeks to 11 months), children (1–6 years old) and pediatrics (7–16 years old). The breakpoint values for 4-hour infusions of 50 mg/kg 4 times daily (200 mg/kg/day) achieved 8 μg/mL (intermediate range of Clinical and Laboratory Standards Institute criteria) in all age groups. Conclusions: This population PK analysis and PD evaluation suggest that higher dosing regimen, especially with extended infusion time, should be reasonable for treating A. baumannii infections in pediatric patients.Keywords
This publication has 39 references indexed in Scilit:
- [Laboratory and clinical studies of sulbactam/ampicillin in pediatric field].1989
- [Clinical and pharmacokinetic studies on intravenous administration of sulbactam/ampicillin in pediatrics].1989
- [Pharmacokinetic and bacteriological studies on sulbactam/ampicillin in the field of pediatrics].1989
- [Pharmacokinetic and clinical studies on sulbactam/ampicillin in the pediatric field].1989
- [Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field].1989
- [Pharmacokinetic and clinical studies on sulbactam/ampicillin in children].1989
- [Clinical evaluation of sulbactam/ampicillin in children].1989
- [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].1989
- [Studies on sulbactam/ampicillin in the field of pediatrics].1989
- [Clinical evaluation of sulbactam/ampicillin in the pediatric infections].1989